DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 97 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $2,947,000 | -4.8% | 115,259 | -17.9% | 0.00% | 0.0% |
Q4 2020 | $3,095,000 | +16.5% | 140,471 | -4.9% | 0.00% | 0.0% |
Q3 2020 | $2,656,000 | -27.9% | 147,653 | +1.8% | 0.00% | -50.0% |
Q2 2020 | $3,683,000 | +70.8% | 144,990 | +23.5% | 0.00% | +33.3% |
Q1 2020 | $2,156,000 | -17.9% | 117,375 | -1.5% | 0.00% | +50.0% |
Q4 2019 | $2,625,000 | +78.1% | 119,175 | +16.1% | 0.00% | +100.0% |
Q3 2019 | $1,474,000 | +40.0% | 102,675 | +53.6% | 0.00% | 0.0% |
Q2 2019 | $1,053,000 | +28.9% | 66,839 | +19.8% | 0.00% | 0.0% |
Q1 2019 | $817,000 | -29.6% | 55,800 | -48.6% | 0.00% | -50.0% |
Q4 2018 | $1,161,000 | -15.8% | 108,587 | +20.1% | 0.00% | 0.0% |
Q3 2018 | $1,379,000 | +97.6% | 90,387 | +58.6% | 0.00% | +100.0% |
Q2 2018 | $698,000 | +78.1% | 57,000 | +39.0% | 0.00% | 0.0% |
Q1 2018 | $392,000 | +5.9% | 41,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $370,000 | +56.8% | 41,000 | 0.0% | 0.00% | – |
Q3 2017 | $236,000 | +81.5% | 41,000 | 0.0% | 0.00% | – |
Q2 2017 | $130,000 | -6.5% | 41,000 | 0.0% | 0.00% | – |
Q1 2017 | $139,000 | +17.8% | 41,000 | 0.0% | 0.00% | – |
Q4 2016 | $118,000 | -51.0% | 41,000 | 0.0% | 0.00% | – |
Q3 2016 | $241,000 | +95.9% | 41,000 | 0.0% | 0.00% | – |
Q2 2016 | $123,000 | -44.1% | 41,000 | 0.0% | 0.00% | – |
Q1 2016 | $220,000 | -54.8% | 41,000 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $487,000 | – | 41,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 4,080,237 | $74,954,000 | 12.68% |
Aquilo Capital Management, LLC | 1,237,379 | $22,731,000 | 8.86% |
EcoR1 Capital, LLC | 3,346,301 | $61,472,000 | 6.42% |
RTW INVESTMENTS, LP | 6,963,135 | $127,913,000 | 5.51% |
BRIDGER MANAGEMENT, LLC | 1,679,344 | $30,850,000 | 3.57% |
Parkman Healthcare Partners LLC | 300,805 | $5,526,000 | 2.56% |
ACUTA CAPITAL PARTNERS, LLC | 256,500 | $4,712,000 | 2.28% |
Integral Health Asset Management, LLC | 185,000 | $3,398,000 | 1.50% |
DAFNA Capital Management LLC | 147,714 | $2,714,000 | 1.13% |
EAM Global Investors LLC | 88,465 | $1,625,000 | 0.95% |